Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda

AIDS Research and Human Retroviruses

Volumn 28, Issue 12, 2012, Pages 1647-1657

  Musiime, Victor ^a   Kayiwa, Joshua ^a   Kiconco, Mary ^b   Tamale, William ^c   Alima, Hillary ^d   Mugerwa, Henry ^e   Abwola, Mary ^f   Apilli, Eunice ^g   Ahimbisibwe, Fred ^a   Kizito, Hilda ^a   Abongomera, George ^h   Namusoke, Asia ^a   Makabayi, Agnes ^f   Kiweewa, Francis ^a   Ssali, Francis ^a   Kityo, Cissy ^a   Colebunders, Robert ⁱ   Mugyenyi, Peter ^a  

^a JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^b Fort Portal Regional Centre of Excellence   (Uganda)

^c Joint Clinical Research Centre   (Uganda)

^d Joint Clinical Research Centre   (Uganda)

^e Joint Clinical Research Centre   (Uganda)

^f Joint Clinical Research Centre   (Uganda)

^g Lira Regional Referral Hospital   (Uganda)

^h Gulu Regional Centre of Excellence   (Uganda)

ⁱ UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ANTIRETROVIRAL THERAPY; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL AREA; SCHOOL CHILD; SELF REPORT; TREATMENT FAILURE; TREATMENT RESPONSE; UGANDA; URBAN AREA; VIRUS LOAD;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; RURAL POPULATION; TREATMENT OUTCOME; UGANDA; URBAN POPULATION;

EID: 84870007679     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0313     Document Type: Article

References (36)

1. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc 2011;14:7.
2. Anaky MF, Duvignac J, Wemin L, et al.: Scaling up anti-retroviral therapy for HIV-infected children in Cote d'Ivoire: Determinants of survival and loss to programme. Bull World Health Organ 2010;88:490-499.
3. Kekitiinwa A, Lee KJ, Walker AS, et al.: Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 2008;49:384-392.
4. Kiboneka A, Wangisi J, Nabiryo C, et al.: Clinical and im-munological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS 2008;22:2493-2499.
5. Memirie ST: Clinical outcome of children on HAART at police referral hospital, Addis Ababa, Ethiopia. Ethiop Med J 2009;47:159-164.
6. Musoke PM, Mudiope P, Barlow-Mosha LN, et al.: Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: A prospective cohort study. BMC Pediatr 2010;10:56.
7. Sauvageot D, Schaefer M, Olson D, Pujades-Rodriguez M, and O'Brien DP: Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children < 5 years of age. Pediatrics 2010;125:e1039-1047.
8. Song R, Jelagat J, Dzombo D, et al.: Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya. Pediatrics 2007;120:e856-861.
9. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, and Moss WJ: Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008;8:477-489.
10. Byrnes RM: Uganda: A country study. 1990. http://coun-trystudies.us/ uganda. Accessed on October 1, 2011.
11. Infoplease: Uganda: Land and People. www.inforplease.com. accessed on October 1, 2011.
12. van Kooten Niekerk NK, Knies MM, Howard J, et al.: The first 5 years of the family clinic for HIV at Tygerberg Hospital: Family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr 2006;52:3-11.
13. Fatti G, Bock P, Grimwood A, and Eley B: Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: A retrospective cohort study. J Int AIDS Soc 2010;13:46.
14. van Dijk JH, Sutcliffe CG, Munsanje B, et al.: HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One 2011;6:e19006.
15. Nyandiko WM, Mwangi A, Ayaya SO, et al.: Characteristics of HIV-infected children seen in Western Kenya. East Afr Med J 2009;86:364-373.
16. Janssen N, Ndirangu J, Newell ML, and Bland RM: Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child 2009;95:414-421.
17. Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, and Nyan-diko WM: Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr 2008;49:163-170.
18. Naidoo R, Rennert W, Lung A, Naidoo K, and McKerrow N: The influence of nutritional status on the response to HAART in HIV-infected children in South Africa. Pediatr Infect Dis J 2010;29:511-513.
19. Biadgilign S, Deribew A, Amberbir A, and Deribe K: Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA J 2009;6:148-154.
20. Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Byakika-Tusiime J, and Musoke P: Adherence to anti-retroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr 2007;27:123-131.
21. White YR, Pierre RB, Steel-Duncan J, et al.: Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica. West Indian Med J 2008;57:231-237.
22. Skovdal M, Campbell C, Madanhire C, Nyamukapa C, and Gregson S: Challenges faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV-infected children in Zimbabwe. AIDS Care 2011;23:957-964.
23. JCRC:2008 Annual report. www.jcrc.org.ug. Accessed on September 24, 2011.
24. JCRC: The Regional Expansion of Antiretroviral therapy (TREAT) annual report, 2008. www.jcrc.org.ug. Accessed on September 24, 2011.
25. WHO: Antiretroviral therapy of HIV infection in infants and children. Recommendations for a public health approach (2006 revision). http://www.who.int/hiv/pub/paediatric/infants/en/index.html. Accessed on October 1, 2011.
26. Okolo CO, Reidpath DD, and Allotey P: Socioeconomic inequalities in access to health care: Examining the case of Burkina Faso. J Health Care Poor Underserved 2011;22:663-682.
27. Zere E, Oluwole D, Kirigia JM, Mwikisa CN, and Mbeeli T: Inequities in skilled attendance at birth in Namibia: A decomposition analysis. BMC Pregnancy Childbirth 2011; 11:34.
28. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, and Maartens G: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007;146:564-573.
29. Nachega JB, Hislop M, Nguyen H, et al.: Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Ac-quir Immune Defic Syndr 2009;51:65-71.
30. Nolan S, Milloy MJ, Zhang R, et al.: Adherence and plasma HIV RNA response to antiretroviral therapy among HIVseropositive injection drug users in a Canadian setting. AIDS Care 2011;23:980-987.
31. Nachega JB, Chaisson RE, Goliath R, et al.: Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. AIDS 2010;24:1273-1280.
32. Mellins CA, Brackis-Cott E, Dolezal C, and Abrams EJ: The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004;23:1035-1041.
33. Brooks-Gunn J and Furstenberg FF Jr: Coming of age in the era of AIDS: Puberty, sexuality, and contraception. Milbank Q 1990;68(Suppl 1):59-84.
34. Hoffman ND, Futterman D, and Myerson A: Treatment issues for HIV-positive adolescents. AIDS Clin Care 1999;11:17-19, 21, 23-24.
35. Mendle J, Harden KP, Brooks-Gunn J, and Graber JA: Development's tortoise and hare: Pubertal timing, pubertal tempo, and depressive symptoms in boys and girls. Dev Psychol 2010;46:1341-1353.
36. Ndondoki C, Dabis F, Namale L, et al.: [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: Systematic review, 2004-2009]. Presse Med 2011;40:e338-357.